Current evidence does not support the use of convalescent plasma in the standard therapy for COVID-19  At the end of the 19th century, Emil von Behring (figure 1) demonstrated that serum from horses infected with diphtheria or tetanus was useful in treating people affected by these diseases, inaugurating passive immunisation as a new therapeutic strategy. […]

Read more of this post


This free site is ad-supported. Learn more